Product Unit size Cat. code Docs. Qty. Price


pDRIVE bearing human c-erbB2 promoter - LacZ

Show product

20 µg



pDRIVE bearing human c-erbB2 promoter - SEAP

Show product

20 µg



pDRIVE bearing human c-erbB2 promoter - Lucia

Show product

20 µg

  • About
  • Specifications
  • pDRIVE contents
  • Details

C-erbB2/neu oncogene (neu+) in pDRIVE expression plasmid

C-erbB2/neu oncogene (neu+) encodes a 185 kDa transmembrane protein with intrinsic tyrosine kinase activity, highly homologous with the epidermal growth factor receptor. The oncogene c-erbB2 is overexpressed in approximately one-third of breast and pancreatic tumors (and in a smaller proportion of other tumors). This overexpression involves transcriptional up-regulation of the c-erbB2 gene. The c-erbB2 promoter was shown to drive specific expression in cells overexpressing the oncogene [1]. Basal activity of the c-erbB2 promoter is equivalent to one third of the herpes simplex thymidine kinase promoter but can be significantly induced by several agents such as epidermal growth factor, dibutyryl cAMP and retinoic acid [2].



1. Harris JD. et al. 1994. Gene therapy for cancer using tumor-specific prodrug activation. Gene Ther. 1(3):170-5.
2. Hudson LG. et al. 1990. Structure and inducible regulation of the human c-erb B2/neu promoter. J Biol Chem. 265(8):4389-93.

Back to the top


pDRIVE bearing human c-erbB2 promoter - LacZ, SEAP or Lucia
Gene Promoter: c-erbB2/neu Oncogene
Specificity: Breast & pancreas cancer
Backbone: pDRIVE, pDRIVE5-SEAP or pDRIVE5-Lucia
Selection: Zeocin™

Back to the top

pDRIVE contents

  • 20 µg of lyophilized DNA
  • 1 ml of Zeocin™ (100 mg/ml)

room temperature Product is shipped at room temperature

Back to the top
Customer Service
& Technical Support
Shopping cart is empty